Streetbeat News

Stock Prices

DDD

DM

NNDM

SSYS

Stratasys Ltd (SSYS) has announced that it is exploring strategic alternatives following the failure of its merger with Desktop Metal Inc (DM). The company's board has initiated a process to consider options such as a strategic transaction, potential merger, business combination or sale. This comes after Stratasys rejected offers from 3D Systems Corporation (DDD) and Nano Dimension Ltd. (NNDM), stating that they significantly undervalued the company.

Portfolio Pulse from Shivani Kumaresan

September 28, 2023 | 4:46 pm

MU

Micron Technology's Q4 results were largely in line with expectations, but shares fell in early trading. Analysts from BMO Capital Markets, Piper Sandler, Mizuho Securities, Stifel, BofA Securities, Needham, and Morgan Stanley provided their takeaways. Most analysts maintained their ratings, with price targets ranging from $58 to $82. Key points included excess inventory clearing in most end markets, expectations of improving inventory levels, and anticipation of DRAM and NAND pricing improvement into 2024.

Portfolio Pulse from Priya Nigam

September 28, 2023 | 4:45 pm

TSLA

Tesla shares are trading higher amid the ongoing UAW strikes at the company's Big 3 rivals. Morgan Stanley has maintained an Overweight rating and a $400 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:43 pm

FOLD

The FDA has approved Amicus Therapeutics' (NASDAQ:FOLD) Pombiliti and Opfolda for Pompe disease, a rare inherited disease. The two-component therapy is indicated for adults with late-onset Pompe disease who are not improving on their current enzyme replacement therapy. The approval was based on data from the Phase 3 pivotal study (PROPEL). Despite the approval, FOLD shares are down 6.65% at $12.03.

Portfolio Pulse from Vandana Singh

September 28, 2023 | 4:41 pm

NVDA

TSLA

The popularity of AI stocks, particularly Nvidia Corp. (NASDAQ:NVDA), has surged, while interest in electric vehicle stocks like Tesla Inc. (NASDAQ:TSLA) has waned. Over the past year, Nvidia's price has increased by 233.6%, while Tesla's has fallen by 16.5%. Both companies do not pay dividends. Nvidia's PEG ratio suggests it is undervalued, while Tesla's indicates expected significant growth. Analyst consensus suggests a 39.5% upside for Nvidia and a 5.32% downside for Tesla.

Portfolio Pulse from Neer Varshney

September 28, 2023 | 4:40 pm

OP

OceanPal shares are trading higher after Sphinx Investment Corp. increased its stake in the company to 9.1% according to a 13G Filing.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:36 pm

MRNA

A whale investor has taken a bullish stance on Moderna (NASDAQ:MRNA), with 50% of investors opening trades with bullish expectations and 50% with bearish. The whale has been targeting a price range from $65.0 to $120.0 for Moderna over the last 3 months. Argus Research has maintained their Buy rating on Moderna, with a price target of $140.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 4:32 pm

STSS

Sharps Technology has signed an Asset Purchase Agreement to acquire the InjectEZ Facility and the associated $400 million 10-year purchase agreement with Nephron Pharmaceuticals. This news led to a decrease in Sharps Technology's share price.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:32 pm

NOW

ServiceNow (NYSE:NOW) has outperformed the market over the past 5 years by 15.39% on an annualized basis, producing an average annual return of 23.43%. If an investor had bought $1000 of NOW stock 5 years ago, it would be worth $2,839.94 today.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 4:30 pm

EW

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years, producing an average annual return of 19.59%. If an investor had bought $100 of EW stock 15 years ago, it would be worth $1,450.63 today.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 4:30 pm